about
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapyNitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activityNitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity.Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis.Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II).Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer.Sulindac and its metabolites induce carcinogen metabolizing enzymes in human colon cancer cells.Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype.Microarray analysis of altered gene expression in the TM4 Sertoli-like cell line exposed to chromium(III) chloride.Epigenetic and gene expression changes related to transgenerational carcinogenesis.Robustness of the Chen-Dougherty-Bittner procedure against non-normality and heterogeneity in the coefficient of variationItaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumorsA promising bladder cancer detection assay: the HA-HAase test
P50
Q33739233-4CA7201B-C965-42A3-89A0-88250F71341AQ34756677-FA44A5AE-9A8C-47F9-BF6A-3554B0E01001Q35022139-4DE97F9D-AEAF-4E58-8FEB-3AD269791EDFQ36050039-639A7987-5195-4353-AE17-66D2B672F9AFQ36321491-DA01C121-8E60-42B0-B6D4-8DB5086EBC9AQ36735832-93DB9997-9090-457D-AFBC-217D958AFFC4Q37371516-E54A8C44-2CB8-4FDD-8DF5-B7BC17C1F799Q38070137-1FBA060C-89E7-4912-BA54-6B59D2F89CB0Q38321797-A763306E-FA4A-44F7-BDFD-7660F0204731Q38344991-89778A38-865E-41A3-A801-E89DA79775AAQ38351507-14CECCB9-A427-40AC-B99B-B44C7681E59FQ39375950-E978C9AA-B2FE-4E33-BD62-552465C3F6EDQ40055810-2ECB55CD-481E-4431-B1ED-0E249758D997Q40424541-FBF64643-AAA3-4D02-B969-0699D2D7DFB7Q40716946-68980D99-4745-4818-B764-33175356B6BAQ44860298-91145769-FB46-4573-808F-7F8C0C4F04B2Q56890452-219DE891-8786-4B66-A1A5-406FDD5E16A2Q63409314-7EC6625A-D095-4B3F-A95E-AE43D8C2D3E7Q80450538-011DD93D-119B-4AC1-A028-122E41E223AF
P50
description
researcher
@en
wetenschapper
@nl
name
Robert Y S Cheng
@en
Robert Y S Cheng
@es
Robert Y S Cheng
@nl
type
label
Robert Y S Cheng
@en
Robert Y S Cheng
@es
Robert Y S Cheng
@nl
prefLabel
Robert Y S Cheng
@en
Robert Y S Cheng
@es
Robert Y S Cheng
@nl
P106
P2038
Robert_Cheng2
P31
P496
0000-0003-0287-6439